AKAM vs CMPX · P/E 27, rev $2.17B vs $367.4M cap
Akamai Technologies Inc (AKAM) versus Compass Therapeutics Inc. (CMPX) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported CMPX revenue for 2025-09-30 was $0. Net income was -$14.3M. CMPX currently screens at market cap $367.4M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. CMPX currently screens at market cap $367.4M.
Not investment advice. Open the AKAM and CMPX stock pages for the full models.
Not investment advice.